DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LITHOBID

« Back to Dashboard

All Clinical Trials for Lithobid

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00183443	Treatment of Mania Symptoms With Drug Therapy	Completed	National Institute of Mental Health (NIMH)	Phase 3	2005-02-01	This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00183443	Treatment of Mania Symptoms With Drug Therapy	Completed	Palo Alto Veterans Institute for Research	Phase 3	2005-02-01	This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00601536	Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2003-04-01	The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fasting conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
NCT00602394	Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions	Completed	Roxane Laboratories	N/A	2003-05-01	The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fed conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
NCT00627887	Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression	Completed	Uppsala-Örebro Regional Research Council	Phase 4	2008-01-01	The purpose of the study is to determine if continuation electroconvulsive therapy (ECT) is safe and effective in relapse prevention of depression.
NCT00627887	Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression	Completed	Örebro County Council	Phase 4	2008-01-01	The purpose of the study is to determine if continuation electroconvulsive therapy (ECT) is safe and effective in relapse prevention of depression.

Clinical Trial Conditions for Lithobid

Condition Name

Condition Name for Lithobid
Intervention	Trials
Bipolar Disorder	4
Bipolar Affective Disorder	1
Asthma: [Nos] or [Attack]	1
Treatment Resistant Depression	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lithobid
Intervention	Trials
Bipolar Disorder	5
Depressive Disorder	3
Depression	3
Disease	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lithobid

Trials by Country

Trials by Country for Lithobid
Location	Trials
United States	14
Sweden	2
Canada	1
Norway	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lithobid
Location	Trials
Texas	2
Pennsylvania	2
California	2
Minnesota	1
New Mexico	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lithobid

Clinical Trial Phase

Clinical Trial Phase for Lithobid
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	1
Phase 2	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lithobid
Clinical Trial Phase	Trials
Completed	4
Enrolling by invitation	1
Not yet recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lithobid

Sponsor Name

Sponsor Name for Lithobid
Sponsor	Trials
Roxane Laboratories	2
Montana State University	1
Uppsala-Örebro Regional Research Council	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lithobid
Sponsor	Trials
Other	13
NIH	2
Industry	2

Export unavailable in trial.
Subscribe for complete access.